Vimta Labs Ltd. NSE: VIMTALABS | BSE: 524394

Mid-range Performer

Download real time

484.50 -29.35 (-5.71%)

105.28% Gain from 52W Low

126.8K

NSE+BSE Volume

NSE 16 Jun, 2025 10:31 AM (IST)

Vimta Labs Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Vimta Labs Ltd. on BSE

Load latest

Vimta Labs Ltd.

30 Sep 2024

484.50

-5.71%

SAST

VIMTA LABS LTD.-$ - 524394 - Closure of Trading Window

BSE India

Intimation for closure of trading window for the second quarter ended 30th September, 2024.

Vimta Labs Ltd.

11 Sep 2024

484.50

-5.71%

Corp. Note

VIMTA LABS LTD.-$ - 524394 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Intimation regarding receipt of Information for loss of share certificate.

Vimta Labs Ltd.

30 Aug 2024

484.50

-5.71%

Company Update

VIMTA LABS LTD.-$ - 524394 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release- Execution of Business Transfer Agreement

Vimta Labs Ltd.

30 Aug 2024

484.50

-5.71%

Company Update

VIMTA LABS LTD.-$ - 524394 - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

BSE India

This is to inform you that the company has entered into Business Transfer Agreement ("BTA") on 30th August, 2024 around 11:00 AM with inter-alia, Thyrocare Technologies Limited (Thyrocare). By this agreement, our company will be transferring and selling its Diagnostics and pathological services business to Thyrocare as a going concern (on slump sale basis). Th said transfer is subject to fulfilment of the Condition Precedent ("CP").

Vimta Labs Ltd.

23 Aug 2024

484.50

-5.71%

Company Update

VIMTA LABS LTD.-$ - 524394 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

BSE India

Intimation of schedule of Analysts/ Institutional Investor Meet.

Vimta Labs Ltd.

12 Aug 2024

484.50

-5.71%

Company Update

VIMTA LABS LTD.-$ - 524394 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Please find the enclosed the published newspaper advertisement in Business Standard (English) and Nava Telangana (Telugu) on 12th August, 2024 regarding notice of hearing of petition fixed before the NCLT on 23.09.2024 in the matter of Amalgamation of EMTAC Laboratories Pvt Ltd and Vimta labs Limited.

Vimta Labs Ltd.

01 Aug 2024

484.50

-5.71%

Corp. Note

VIMTA LABS LTD.-$ - 524394 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / …

BSE India

Intimation in terms of Regulation 39(3) of SEBI (LODR) Regulations, 2015 - Issue of duplicate share certificates.

Vimta Labs Ltd.

29 Jul 2024

484.50

-5.71%

Company Update

VIMTA LABS LTD.-$ - 524394 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

Disclosure on Credit Rating.

Vimta Labs Ltd.

24 Jul 2024

484.50

-5.71%

Earnings Call

VIMTA LABS LTD.-$ - 524394 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Transcript of the Q1-2025 earning/investor call held on 18th July, 2024.

Vimta Labs Ltd.

23 Jul 2024

484.50

-5.71%

Earnings Call

VIMTA LABS LTD.-$ - 524394 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Audio Recording of the Q1-2025 earnings/investor call held on 18th July 2024.

Is Vimta Labs Ltd. worth buying?

75 Votes:

Buy 74.67%

Sell 14.67%

Hold 10.67%